Gastroenterology

The AJMC® Gastroenterology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the stomach, digestive tract, colon, and more.

Latest News
February 24th 2025

Crohn Disease Subtype, Ocular Manifestation Among Risk Factors for EIMs in IBD

February 21st 2025

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

February 20th 2025

Disease Activity, Safety Remain Following Switch From Infliximab Biosimilar to Originator in IBD

February 18th 2025

How Medical Media Is Shaping Gastroenterology and Hepatology

February 11th 2025

Abstracts Highlight Access Barriers, CV Risks Associated With IBD Care

Video Interviews
View All
January 12th 2025

Personalized Medicine in GI Cancer: Transforming Treatment With Technology, Lifestyle Insights

January 4th 2025

Empowering Patients With GI Cancer: Overcoming Immunotherapy Limitations

Continuing Medical Education
View All
March 3rd 2025

Navigating Next-Generation Therapies for the Management of Acid-Related Disorders

1.5 Credits / Gastroenterology
March 3rd 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

More News

ulcerative colitis | Image credit: sdecoret - stock.adobe.com
February 6th 2025

Mirikizumab Demonstrates Superior Maintenance Efficacy in UC Treatment

Skylar Jeremias
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network meta-analysis comparing biologics and small molecules.
gallstones | Image credit: Crystal light - stock.adobe.com
February 4th 2025

PROSPERO Identifies Key Risk Factors for Gallstones in Crohn Disease

Skylar Jeremias
The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition significantly increase the risk of gallstone disease in patients with Crohn disease.
IBD-D | Image credit: eddows - stock.adobe.com
February 3rd 2025

FDA Grants Tentative Approval to Generic Version of Rifaximin for IBS-D

Abigail Brooks, MA
The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s involvement in litigation.
liver and hepatitis B infection | Image credit: Rasi - stock.adobe.com
February 1st 2025

New AGA Guidelines Recommend Risk-Based Prophylaxis for Hepatitis B Reactivation Monitoring

Skylar Jeremias
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B reactivation (HBVr) in at-risk individuals, recommending antiviral prophylaxis for high- and moderate-risk patients.
inflammatory bowel disease | Image credit: sdecoret - stock.adobe.com
January 24th 2025

FDA Approves Mirikizumab for Crohn Disease

Skylar Jeremias
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach to now include the full spectrum of inflammatory bowel disease.
guy with stomach discomfort after eating bread, celiac | Image credit: weyo - stock.adobe.com
January 23rd 2025

Gene Variant, Season of Birth Identified as Celiac Disease Risk Factors

Skylar Jeremias
Children born in spring or summer with a specific gene variant may have a higher risk of celiac disease and lower levels of a key protein, according to a study, potentially helping future research on autoimmune diseases.
positive covid-19 test | Image credit: JOE LORENZ DESIGN - stock.adobe.com
January 14th 2025

Study Finds Link Between COVID-19 and Elevated Risk of GI Disorders

Skylar Jeremias
A study found that patients with COVID-19 may have a higher risk of developing new gastrointestinal (GI) disorders compared with matched controls, highlighting the need for further research on long-term GI effects post COVID-19 infection.
norovirus test | Image credit: jarun011 - stock.adobe.com
January 14th 2025

Entering Peak Norovirus Season as Cases Rise Across the US

Sophia Abene
Nationwide norovirus cases have recently increased, followed by an FDA warning for consumers to avoid oysters contaminated in a recent outbreak.
digestive tract and IBS/IBD | Image credit: Grispb - stock.adobe.com
January 13th 2025

What Adjunct Therapies Are Most Effective for IBS, IBD?

Skylar Jeremias
A study suggests that adjunct therapies, including the Mediterranean diet, physical activity, and cognitive behavioral therapy, may help alleviate persistent digestive symptoms and improve quality of life for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), alongside standard drug treatments.
digestive trouble doll | Image credit: Alrandir - stock.adobe.com
January 9th 2025

Prucalopride Tablets for Chronic Idiopathic Constipation Launches, Approved for 180-Day CGT Designation

Gillian McGovern
The tablets are indicated for treatment of adults with chronic idiopathic constipation, with further research needed to assess efficacy and safety in children.
inflammatory bowel disease | Image credit: Aliaksandr Marko - stock.adobe.com
January 7th 2025

Stable Patient Satisfaction Found After Switching From Humira or Biosimilar Adalimumab to CT-P17

Deana Ferreri, PhD
A real-world study in France found patient satisfaction was stable after switching from either the reference product or a low-concentration adalimumab biosimilar to the adalimumab biosimilar CT-P17, a high-concentration, citrate-free formulation.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo